Clear All
11120 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
61570-0072-01 61570-0072 Esterified Estrogens Menest 0.3 mg/1 Hormonal Therapy Estrogen Oral Sep 28, 1977 In Use
54868-2702-00 54868-2702 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Nov 16, 2004 In Use
55154-0217-04 55154-0217 conjugated estrogens Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 May 31, 2013 No Longer Used
50090-1853-03 50090-1853 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jun 2, 2015 In Use
00046-1100-91 00046-1100 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 In Use
54868-2702-01 54868-2702 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Nov 16, 2004 In Use
54868-6211-01 54868-6211 Estrogens, Esterified Menest 0.3 mg/1 Hormonal Therapy Estrogen Oral Dec 9, 2010 In Use
35356-0249-00 35356-0249 Estrogens, Conjugated, conjugated estrogens Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Mar 22, 2012 Dec 31, 2014 No Longer Used
54868-6211-00 54868-6211 Estrogens, Esterified Menest 0.3 mg/1 Hormonal Therapy Estrogen Oral Dec 9, 2010 In Use
54569-0811-03 54569-0811 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 In Use
55154-0217-00 55154-0217 conjugated estrogens Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 Feb 28, 2014 No Longer Used
55154-0217-06 55154-0217 conjugated estrogens Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 Feb 28, 2014 No Longer Used
00046-1100-52 00046-1100 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Nov 11, 2019 In Use
00008-0100-01 00008-0100 Inotuzumab Ozogamicin Besponsa 0.25 mg/mL Immunotherapy Drug Antibody Conjugate CD22 Intravenous Aug 18, 2017 In Use
60505-6193-01 60505-6193 Palonosetron Hydrochloride Palonosetron 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sep 19, 2018 In Use
67457-0317-25 67457-0317 Palonosetron Hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sep 20, 2018 In Use
83703-0531-02 83703-0531 Palonosetron hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Nov 12, 2021 In Use
63323-0673-89 63323-0673 Palonosetron Palonosetron 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sep 19, 2018 In Use
36000-0326-02 36000-0326 palonosetron hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Nov 12, 2021 In Use
62856-0797-01 62856-0797 Palonosetron hydrochloride Aloxi 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous May 28, 2014 Oct 31, 2022 No Longer Used
63323-0673-05 63323-0673 Palonosetron Palonosetron 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sep 19, 2018 In Use
00703-4094-01 00703-4094 Palonosetron Hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Mar 23, 2018 In Use
00781-3312-95 00781-3312 Palonosetron Hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Oct 1, 2024 In Use
16729-0365-66 16729-0365 palonosetron hydrochloride palonosetron hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Mar 23, 2018 Nov 30, 2022 No Longer Used
71288-0409-05 71288-0409 Palonosetron Hydrochloride Palonosetron Hydrochloride 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Aug 14, 2023 In Use

Found 11120 results — Export these results